Edwards Lifesciences (EW) Short term Debt (2009 - 2018)
Edwards Lifesciences' (EW) quarterly Short term Debt came in at $598.6 million in Q1 2018, up 1057.83% quarter-over-quarter from $51.7 million in Q4 2017.
Edwards Lifesciences (EW) Short term Debt (2009 - 2018) Analysis & Trends
Edwards Lifesciences' Short term Debt history runs 6 years deep, the most recent figure standing at $598.6 million for Q1 2018.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $598.6 million in Q1 2018; TTM through Mar 2018 was $598.6 million, a N/A change from a year earlier, with the FY2017 full-year figure at $51.7 million, changed N/A from the prior year.
- Short term Debt climbed to $598.6 million in Q1 2018 per EW's latest filing, from $51.7 million in the prior quarter.
- Across five years, Short term Debt topped out at $598.6 million in Q1 2018 and bottomed at $41.5 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 598.60 Mn |
| Dec 31, 2017 | 51.70 Mn |
| Sep 30, 2017 | 41.50 Mn |
| Dec 31, 2012 | 189.30 Mn |
| Dec 31, 2011 | 150.40 Mn |
| Mar 31, 2011 | 149.50 Mn |
| Dec 31, 2010 | 41.80 Mn |
| Sep 30, 2010 | 100.60 Mn |
| Dec 31, 2009 | 11.40 Mn |